ESPR

Esperion Therape

• NASDAQ·2d ago

  Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?

• TipRanks·5d ago

  Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), PROCEPT BioRobotics (PRCT) and Vericel (VCEL)

• TipRanks·04/02 21:33

  Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio

• Reuters·04/02 20:29

  ESPERION THERAPEUTICS INC - INCURS $25 MLN IN ADDITIONAL TERM LOANS ON APRIL 2, 2026 - SEC FILING

• TipRanks·04/02 20:16

  Esperion, Athyrium Capital enter $50M royalty financing agreement

• Reuters·04/02 20:08

  Esperion enters $50 million Japan royalty financing with Athyrium Capital Management

• Reuters·04/02 20:05

  ESPERION THERAPEUTICS INC - ATHYRIUM FUNDS TO BUY 100% OF ESPERION'S ROYALTY INTEREST ON OTSUKA'S JAPAN SALES FROM JAN 1, 2026

• Reuters·04/02 20:00

  Esperion closes acquisition of Corstasis, adds Enbumyst nasal spray diuretic

• Dow Jones·04/02 20:00

  *Esperion Therapeutics Closes Acquisition Of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise With Enbumyst(TM) (bumetanide Nasal Spray) >ESPR

• TipRanks·04/02 00:05

  Esperion Therapeutics Earnings Call Signals Expansion

• Reuters·03/31 21:52

  Esperion to present at Needham Virtual Healthcare Conference webcast

• TipRanks·03/31 10:38

  Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise

• TipRanks·03/31 08:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Passage Bio (PASG), Phreesia (PHR) and Esperion (ESPR)

• Seeking Alpha·03/30 18:54

  Merck oral PCSK9 enlicitide shows improved cholesterol lowering vs. non-statins

• TipRanks·03/30 13:21

  Esperion showcases new data from CLEAR Outcomes trial